Smith & Nephew plc (LON:SN - Get Free Report)'s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,050.36 ($14.28) and traded as high as GBX 1,113 ($15.13). Smith & Nephew shares last traded at GBX 1,107 ($15.05), with a volume of 701,549 shares traded.
Smith & Nephew Stock Down 0.2%
The company has a market cap of £12.16 billion, a P/E ratio of 39.93, a price-to-earnings-growth ratio of 0.46 and a beta of 0.62. The company has a 50 day moving average of GBX 1,083.28 and a 200-day moving average of GBX 1,052.67. The company has a debt-to-equity ratio of 70.22, a current ratio of 2.51 and a quick ratio of 0.84.
Insider Activity at Smith & Nephew
In related news, insider Jeremy (Jez) Maiden acquired 1,855 shares of the firm's stock in a transaction dated Thursday, May 1st. The shares were purchased at an average price of GBX 1,070 ($14.55) per share, for a total transaction of £19,848.50 ($26,982.74). Corporate insiders own 0.19% of the company's stock.
About Smith & Nephew
(
Get Free Report)
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.
See Also
Before you consider Smith & Nephew, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Smith & Nephew wasn't on the list.
While Smith & Nephew currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
